Indian Journal of Urology Users online:473  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
Year : 1985  |  Volume : 1  |  Issue : 2  |  Page : 59-70

An overview of evolving drug therapy for disorders of micturition and its clonical implication.

Division of Urology, Hahnemann University, Philadelphia, U.S.A

Correspondence Address:
O P Khanna
Division of Urology, Hahnemann University, Philadelphia, U.S.A

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Current experimental evidence suggests that the peripheral innervation of vesicourethral smooth muscle is complex and diversified. The following peripheral nerves affect urethral and vesical functions: Cholinergic, adrenergic, purinergic, peptidergic and histaminergic neurons. Prostaglandins, 5-hydroxytryptamine (5-HT) and sex hormones may also influence urethral and vesical functions. Formerly, detrusor activity was increased or decreased using cholinergic or anticholinergic agents. Now, more complex patterns of chemical manipulation are suggested, with the aim of directly affecting multiple site such as the autonomic ganglia, peripheral neurons, end-organ receptors and even the smooth muscle itself. Based on his clinical experience and knowledge of the effects of various drugs on the vesicourethral smooth muscle, the author recommends drug therapy for micturition disorders.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal